Irina Bancos
Mayo Clinic (Rochester, Minnesota , US) · Mayo Clinic
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Irina Bancos as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:30 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07247162 · Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's SyndromeRECORDATI GROUP · recruiting · Hypertension, Hypercortisolemia, Cushing Syndrome · study chair
- Ph2NCT07138274 · Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACSMayo Clinic · recruiting · Mild Autonomous Cortisol Secretion (MACS), Autonomous Cortisol Secretion (ACS) · principal investigator
- Ph2NCT07104812 · Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS)Mayo Clinic · recruiting · Mild Autonomous Cortisol Secretion, Autonomous Cortisol Secretion (ACS) · principal investigator
- Ph2NCT06106295 · Metyrapone for Mild Autonomous Cortisol Secretion (MACS)Mayo Clinic · active not recruiting · Autonomous Cortisol Secretion, Mild Autonomous Cortisol Secretion (MACS) · principal investigator
- N/ANCT04543253 · Recovery From Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS)Mayo Clinic · recruiting · Cushing Syndrome · principal investigator
- N/ANCT04343560 · MACS and Healthy Volunteers Bone StudyMayo Clinic · completed · MACS Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Reversing abnormal metabolism in mild autonomous cortisol secretion (MACS)R01DK145578 · NIDDK · MAYO CLINIC ROCHESTER · fiscal years 2026 · $741,387 awarded in 2026Same name and institution; not confirmed by an ID
- Impact of abnormal steroid metabolome on cellular senescence, frailty and cognitionR03DK132121 · NIDDK · MAYO CLINIC ROCHESTER · fiscal years 2022 to 2023 · $119,250 awarded in 2023Same name and institution; not confirmed by an ID
- Impact of menopause associated adrenal aging on cognitive function and Alzheimer dementia neuroimaging biomarkersR03AG071934 · NIA · MAYO CLINIC ROCHESTER · fiscal years 2022 to 2023 · $154,376 awarded in 2023Same name and institution; not confirmed by an ID
- Skeletal Consequences of Mild Autonomous Cortisol SecretionK23DK121888 · NIDDK · MAYO CLINIC ROCHESTER · fiscal years 2019 to 2022 · $157,112 awarded in 2022Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:30 UTC. The ranking covers the 200 most relevant of 8 PubMed records, and a shared surname and initials can bring in a namesake. All 8 on PubMed
- Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial.Nat Med · 2024113 citationsRCR 15.2
- Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study.Lancet Diabetes Endocrinol · 202379 citationsRCR 10.2
- Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study.Front Endocrinol (Lausanne) · 202165 citationsRCR 4.7
- THE EVALUATION OF INCIDENTALLY DISCOVERED ADRENAL MASSES.Endocr Pract · 201959 citationsRCR 3.6
- Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia.N Engl J Med · 202453 citationsRCR 9.9
- Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.Diabetes Care · 202529 citationsRCR 7.3
- Teriparatide Therapy and Reduced Postoperative Hospitalization for Postsurgical Hypoparathyroidism.JAMA Otolaryngol Head Neck Surg · 201520 citationsRCR 1.1
- Efficacy and Safety of Once-Weekly Lonapegsomatropin in Adults With Growth Hormone Deficiency: foresiGHt Trial Results.J Clin Endocrinol Metab · 20267 citationsRCR 3.5